Insmed
INSM
#625
Rank
NZ$64.69 B
Marketcap
NZ$303.35
Share price
4.98%
Change (1 day)
143.43%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -NZ$1.9 Billion

According to Insmed's latest financial reports the company's current earnings are NZ$0.44 Billion. In 2024 the company made an earning of -NZ$1.44 Billion a decrease over its 2023 earnings that were of -NZ$1.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$1.9 Billion31.52%
2024 -NZ$1.44 Billion23.71%
2023 -NZ$1.17 Billion45.77%
2022 -NZ$0.8 Billion15.83%
2021 -NZ$0.69 Billion50.19%
2020 -NZ$0.46 Billion16.4%
2019 -NZ$0.4 Billion-23.9%
2018 -NZ$0.52 Billion59.35%
2017 -NZ$0.33 Billion8.52%
2016 -NZ$0.3 Billion47.25%
2015 -NZ$0.21 Billion34.53%
2014 -NZ$0.16 Billion58.83%
2013 -NZ$95.22 Million35.14%
2012 -NZ$70.47 Million-31.92%
2011 -NZ$0.11 Billion854.92%
2010 -NZ$10.84 Million-105.22%
2009 NZ$0.20 B-905.06%
2008 -NZ$25.78 Million-27.31%
2007 -NZ$35.47 Million-62.41%
2006 -NZ$94.34 Million98.19%
2005 -NZ$47.6 Million0.03%
2004 -NZ$47.59 Million159.07%
2003 -NZ$18.37 Million-69.31%
2002 -NZ$59.85 Million
2000 -NZ$53.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-NZ$0.44 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.48 B-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ$17.15 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ$7.65 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$40.33 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$7.74 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA